RU99108641A - DRUG AND METHOD FOR TREATING EPILEPSY AND SCHIZOPHRENIA - Google Patents

DRUG AND METHOD FOR TREATING EPILEPSY AND SCHIZOPHRENIA

Info

Publication number
RU99108641A
RU99108641A RU99108641/14A RU99108641A RU99108641A RU 99108641 A RU99108641 A RU 99108641A RU 99108641/14 A RU99108641/14 A RU 99108641/14A RU 99108641 A RU99108641 A RU 99108641A RU 99108641 A RU99108641 A RU 99108641A
Authority
RU
Russia
Prior art keywords
drug
schizophrenia
treating epilepsy
decoction
viburnum
Prior art date
Application number
RU99108641/14A
Other languages
Russian (ru)
Other versions
RU2163815C2 (en
Inventor
Елена Сергеевна Солодовникова
Светлана Ивановна Кутнякова
Original Assignee
Елена Сергеевна Солодовникова
Светлана Ивановна Кутнякова
Filing date
Publication date
Application filed by Елена Сергеевна Солодовникова, Светлана Ивановна Кутнякова filed Critical Елена Сергеевна Солодовникова
Priority to RU99108641/14A priority Critical patent/RU2163815C2/en
Priority claimed from RU99108641/14A external-priority patent/RU2163815C2/en
Publication of RU99108641A publication Critical patent/RU99108641A/en
Application granted granted Critical
Publication of RU2163815C2 publication Critical patent/RU2163815C2/en

Links

Claims (3)

1. Применение внутривенно смеси перекиси водорода и отвара коры калины в качестве препарата для лечения эпилепсии и шизофрении.1. The use of an intravenous mixture of hydrogen peroxide and decoction of viburnum bark as a drug for the treatment of epilepsy and schizophrenia. 2. Применение препарата по п.1, содержащего смесь перекись водорода 0,15 - 0,20% по 200 мл и отвара коры калины 1 - 2 мл на 100 мл перекиси. 2. The use of the drug according to claim 1, containing a mixture of hydrogen peroxide 0.15-0.20% in 200 ml and a decoction of bark of viburnum 1 to 2 ml per 100 ml of peroxide. 3. Способ лечения эпилепсии и шизофрении, отличающийся тем, что внутривенное вливание препарата, проводят курсами по 10 - 15 вливаний, со скоростью 30 - 60 капель в мин, через 2 - 3 дня, при этом в качестве препарата используют смесь перекись водорода в дозировке 0,15 - 0,20% по 200 мл и отвара коры калины 1 - 2 мл на 100 мл перекиси. 3. A method of treating epilepsy and schizophrenia, characterized in that the intravenous infusion of the drug is carried out in courses of 10 to 15 infusions, at a rate of 30 to 60 drops per minute, after 2 to 3 days, while a mixture of hydrogen peroxide in a dosage is used as the drug 0.15 - 0.20% in 200 ml and a decoction of the bark of viburnum 1 - 2 ml per 100 ml of peroxide.
RU99108641/14A 1999-04-26 1999-04-26 Preparation and method of treatment of patients with epilepsy and schizophrenia RU2163815C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU99108641/14A RU2163815C2 (en) 1999-04-26 1999-04-26 Preparation and method of treatment of patients with epilepsy and schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU99108641/14A RU2163815C2 (en) 1999-04-26 1999-04-26 Preparation and method of treatment of patients with epilepsy and schizophrenia

Publications (2)

Publication Number Publication Date
RU99108641A true RU99108641A (en) 2001-02-10
RU2163815C2 RU2163815C2 (en) 2001-03-10

Family

ID=20219042

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99108641/14A RU2163815C2 (en) 1999-04-26 1999-04-26 Preparation and method of treatment of patients with epilepsy and schizophrenia

Country Status (1)

Country Link
RU (1) RU2163815C2 (en)

Similar Documents

Publication Publication Date Title
DK0913156T3 (en) Use of activated protein C for the treatment of hypercoagulation conditions associated with sepsis
DE69230112D1 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE
EP0333606A3 (en) Preparation of t-cell and t-cell membrane for use in prevention and treatment of autoimmune diseases
IS1694B (en) Medicinal product for administration to oral animals containing proton pump blockers
GEP20053504B (en) Low Dose Entecavir Pharmaceutical Composition and Use Thereof for Treatment of Hepatitis B
ES8608848A1 (en) Intra pocket drug delivery devices for treatment of periondontal diseases.
ATE241378T1 (en) COMBINATIONS OF VASOPRESSIN AND ADRENERGIC ACTIVES FOR THE TREATMENT OF SUDDEN CARDIAC DEATH
GEP20053595B (en) Cyclopentanoindoles, Compositions Containing Such Compounds and Methods of Treatment
PL345959A1 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
BG106171A (en) Compositions and uses of et743 for treating cancer
JP2005504018A5 (en)
DE69424777T2 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
DK0856312T3 (en) Use of trospium chloride for the manufacture of a medicament for the treatment of bladder diseases
RU99108641A (en) DRUG AND METHOD FOR TREATING EPILEPSY AND SCHIZOPHRENIA
ATE178208T1 (en) MEDICINAL CONTAINING CAPSAICIN FOR THE TREATMENT OF CHRONIC RHINOPATHY
IL126795A (en) Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
RU2003118131A (en) METHOD FOR TREATING RAS
SG129278A1 (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof
RU95102346A (en) METHOD FOR TREATING DISCIRCULATORY ENCEPHALOPATHY
RU95113855A (en) METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS
RU2001113054A (en) A method for the treatment of postpartum acute purulent-catarrhal endometritis of cows
RU2002130183A (en) METHOD FOR TREATMENT OF FOCAL TYPES OF THE THYROID GLAND
RU96104214A (en) METHOD FOR TREATING TRANSSUDATIVE FORMS OF CENTRAL CHORIORETHINAL DYSTROPHIES
RO102780B1 (en) General anaesthesia method
RU2004111044A (en) DRUG FOR TREATMENT OF A HEMORRHAGIC STROKE AND METHOD FOR TREATING A HEMORRHAGIC STROKE